BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31745214)

  • 21. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
    Zhao Z; Sui Y; Gao W; Cai B; Fan D
    J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis.
    Lowry KS; Murray SS; McLean CA; Talman P; Mathers S; Lopes EC; Cheema SS
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Sep; 2(3):127-34. PubMed ID: 11771768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis.
    Wang T; Tomas D; Perera ND; Cuic B; Luikinga S; Viden A; Barton SK; McLean CA; Samson AL; Southon A; Bush AI; Murphy JM; Turner BJ
    Cell Death Differ; 2022 Jun; 29(6):1187-1198. PubMed ID: 34857917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
    Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
    Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterizing the multiple roles of FGF-2 in SOD1
    Kefalakes E; Böselt S; Sarikidi A; Ettcheto M; Bursch F; Naujock M; Stanslowsky N; Schmuck M; Barenys M; Wegner F; Grothe C; Petri S
    J Cell Physiol; 2019 May; 234(5):7395-7410. PubMed ID: 30370540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interfering with lysophosphatidic acid receptor edg2/lpa
    Gento-Caro Á; Vilches-Herrando E; García-Morales V; Portillo F; Rodríguez-Bey G; González-Forero D; Moreno-López B
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1004-1018. PubMed ID: 33508894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.
    Lunn JS; Sakowski SA; Kim B; Rosenberg AA; Feldman EL
    Dev Neurobiol; 2009 Nov; 69(13):871-84. PubMed ID: 19672955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1
    Salvany S; Casanovas A; Piedrafita L; Gras S; Calderó J; Esquerda JE
    Brain Pathol; 2022 Nov; 32(6):e13078. PubMed ID: 35584812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.
    Turner BJ; Ackerley S; Davies KE; Talbot K
    Hum Mol Genet; 2010 Mar; 19(5):815-24. PubMed ID: 20008901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
    Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
    Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.
    Zhang X; Chen S; Song L; Tang Y; Shen Y; Jia L; Le W
    Autophagy; 2014 Apr; 10(4):588-602. PubMed ID: 24441414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis.
    Yip PK; Pizzasegola C; Gladman S; Biggio ML; Marino M; Jayasinghe M; Ullah F; Dyall SC; Malaspina A; Bendotti C; Michael-Titus A
    PLoS One; 2013; 8(4):e61626. PubMed ID: 23620776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
    J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice.
    Rao MV; Campbell J; Palaniappan A; Kumar A; Nixon RA
    J Neurochem; 2016 Apr; 137(2):253-65. PubMed ID: 26756888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
    Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
    Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.